Stockreport

These 2 Healthcare Stocks Are Up Over 100% in a Month. Can They Keep Climbing? [Yahoo! Finance]

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations
PDF Nektar is developing an experimental eczema treatment. Millions of patients with stubbornly high blood pressure could benefit from an experimental drug being develope [Read more]